Skip to main content

Clinical Trials › NCT04035005

Active, Not RecruitingPhase 3

A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis

Sponsored by Hoffmann-La Roche

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
1013
Target enrollment
5
U.S. states
Aug 2019
Start date
Jan 2028
Expected completion

Interventions / Treatments

OcrelizumabPlacebo

Conditions studied

Multiple Sclerosis, Primary Progressive

Where this trial is running (8 sites)

Florida3 sites
Clearwater · Orlando · Vero Beach
Ohio2 sites
Columbus · Westerville
Washington D.C.
Kansas1 site
Kansas City
Philadelphia

MS centers in Florida

Compare treatment centers near a trial site by center type, providers and trials.

View Florida centers

More Phase 3 trials

Browse all Phase 3 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play